fda ends semaglutide shortage Over? The FDA's Controversial Claim Shakes GLP-1 Users FDA Announces Resolution of Semaglutide

Documentation Requirements for Your Ozempic Claim Multiple peer-reviewed studies have established a clear mechanistic and epidemiological link between GLP-1 receptor agonists like semaglutide and the development of gastroparesis, with evidence showing these drugs fundamentally alter gastric motility through their intended mechanism of action

Clinical Evidence: Does Semaglutide Directly Cause Hair Loss

Older adults Researchers over 60 may see slightly slower weight loss and face a higher risk of sarcopenia (muscle loss) during treatment

It is also prescribed for long-term weight management in adults and adolescents aged 12 years and older with obesity, and in adults with overweight who have a weight-related health condition